BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
GlobeNewswire
*MAINZ, Germany, May 21, 2024 *– BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data..